The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000132.4(F8):c.1649G>A (p.Arg550His)

CA255115

10225 (ClinVar)

Gene: F8
Condition: hemophilia A
Inheritance Mode: X-linked inheritance
UUID: 2c41fca8-0d9a-4276-9f42-fc7a33592b0f
Approved on: 2024-02-02
Published on: 2024-07-11

HGVS expressions

NM_000132.4:c.1649G>A
NM_000132.4(F8):c.1649G>A (p.Arg550His)
NC_000023.11:g.154957060C>T
CM000685.2:g.154957060C>T
NC_000023.10:g.154185335C>T
CM000685.1:g.154185335C>T
NC_000023.9:g.153838529C>T
NG_011403.1:g.70664G>A
NG_011403.2:g.70664G>A
ENST00000360256.9:c.1649G>A
ENST00000647125.1:c.*1525G>A
ENST00000360256.8:c.1649G>A
NM_000132.3:c.1649G>A

Pathogenic

Met criteria codes 4
PP4_Moderate PS4 PP3 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Coagulation Factor Deficiency Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for F8 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Coagulation Factor Deficiency VCEP
The c.1649G>A (p.Arg550His) variant is absent from males in gnomAD v2.1.1. It is reported in heterozygotes at a frequency of 0.00002442 (2/81904 alleles) in the non-Finnish European population. At least 35 male individuals with mild hemophilia A are found in the literature and internal laboratory data with the Arg550His variant. More cases are available in the literature (EAHAD reports 64 patients), however >8 probands have been counted towards PS4_VeryStrong and one for PP4_moderate. This variant is associated with discrepant factor VIII activity levels with some individuals having normal levels on one-stage assays and levels in the mild hemophilia range on a chromogenic, or two-stage, assay (CDC Champs/EAHAD databases). Some individuals have been reported to have a history of inhibitor formation to factor replacement products (CDC Champs/EAHAD databases). The c.1649G>A (p.Arg550His) missense variant has a REVEL score of 0.78 (>0.6). Other variants at the same residue, Arg550Cys, Arg550Gly, Arg550Leu and Arg550Pro have been reported, but evidence from these variant curations has not been used in classifying the Arg550His variant. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS4_VeryStrong, PP3, PM2_Supporting.
Met criteria codes
PP4_Moderate
Male with mild hemophilia A (17% factor VIII activity) in the MLOF study with full sequencing and deletion/duplication analysis of F8 and F9 genes.
PS4
At least 35 male individuals with mild hemophilia A are found in the literature and internal laboratory data with the Arg550His variant. More cases are available in the literature (EAHAD reports 64 patients), however >8 probands have been counted towards PS4_VeryStrong.
PP3
The c.1649G>A (p.Arg550His) missense variant has a REVEL score of 0.78 (>0.6).
PM2_Supporting
The c.1649G>A (p.Arg550His) variant is absent from males in gnomAD v2.1.1. It is reported in heterozygotes at a frequency of 0.00002442 (2/81904 alleles) in the non-Finnish European population (Absent in v3.1.2).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.